It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Streptomyces are our principal source of antibiotics, which they generate concomitant with a complex developmental transition from vegetative hyphae to spores. c-di-GMP acts as a linchpin in this transition by binding and regulating the key developmental regulators, BldD and WhiG. Here we show that c-di-GMP also binds the glycogen-debranching-enzyme, GlgX, uncovering a direct link between c-di-GMP and glycogen metabolism in bacteria. Further, we show c-di-GMP binding is required for GlgX activity. We describe structures of apo and c-di-GMP-bound GlgX and, strikingly, their comparison shows c-di-GMP induces long-range conformational changes, reorganizing the catalytic pocket to an active state. Glycogen is an important glucose storage compound that enables animals to cope with starvation and stress. Our in vivo studies reveal the important biological role of GlgX in Streptomyces glucose availability control. Overall, we identify a function of c-di-GMP in controlling energy storage metabolism in bacteria, which is widespread in Actinobacteria.
c-di-GMP has emerged as the signal controlling development in antibiotic producing Streptomyces. Here the authors describe another developmental role of c-di-GMP, in energy metabolism, by activating the glycogen-debranchingenzyme, GlgX. Structures revealing the activation mechanism are described.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 Duke University School of Medicine, Department of Biochemistry, Durham, USA (GRID:grid.26009.3d) (ISNI:0000 0004 1936 7961)
2 Humboldt-Universität zu Berlin, Institute for Biology/Microbiology, Berlin, Germany (GRID:grid.7468.d) (ISNI:0000 0001 2248 7639); Bundesinstitut für Risikobewertung, Berlin, Germany (GRID:grid.417830.9) (ISNI:0000 0000 8852 3623)
3 Humboldt-Universität zu Berlin, Institute for Biology/Microbiology, Berlin, Germany (GRID:grid.7468.d) (ISNI:0000 0001 2248 7639)
4 University of California, San Diego, Department of Pediatrics, La Jolla, USA (GRID:grid.266100.3) (ISNI:0000 0001 2107 4242)
5 Leibniz Universität Hannover, Institute of Microbiology, Hannover, Germany (GRID:grid.9122.8) (ISNI:0000 0001 2163 2777)
6 John Innes Centre, Department of Cell and Developmental Biology, Norwich, UK (GRID:grid.14830.3e) (ISNI:0000 0001 2175 7246)